New panel expands coverage for Alzheimer’s and Parkinson’s diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and 12 assays ...
New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...
Proteomics software refers to computational tools and platforms designed to analyze, process, and interpret proteomic data.
Proteomics service providers offer outsourced access to advanced protein analysis technologies, including mass spectrometry ...
TORONTO and SAN FRANCISCO, March 17, 2026 /PRNewswire/ - Dalriada Drug Discovery ("Dalriada"), a partnered discovery organization supporting small-molecule programs from hit identification through ...
New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...
ACR-368, a CHK1/2 inhibitor in a registrational-intent Phase 2b study, showed potent preclinical synergy with Topoisomerase 1 (Topo 1) ...
Researchers at the Josep Carreras Leukaemia Research Institute propose a new view of cancer based on spatial hallmark ecosystems and its evolution during cancer progression. This conceptual framework ...
Aditxt, Inc. (NASDAQ: ADTX) ("Aditxt" or the "Company"), a social innovation platform accelerating promising health innovations, today announced the acquisition of Ignite Proteomics, LLC ("Ignite"), a ...
Early prediction and identification of neurodegenerative diseases offers the best chance for prevention and treatment.
Chronos ‑ PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years before clinical diagnosis Uncovered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results